263 related articles for article (PubMed ID: 25489932)
1. Counterfeit and substandard drugs in India may be smaller problem than claimed, say government findings.
Travasso C
BMJ; 2014 Jan; 348():g60. PubMed ID: 25489932
[No Abstract] [Full Text] [Related]
2. Substandard and counterfeit medicines.
Rassool GH
J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
[No Abstract] [Full Text] [Related]
3. Drug counterfeiting burden remains a guess, experts say.
Traynor K
Am J Health Syst Pharm; 2009 Jul; 66(14):1246-8. PubMed ID: 19574593
[No Abstract] [Full Text] [Related]
4. [Counterfeit and fake drugs: medications that kill].
Ambroise-Thomas P
Med Trop (Mars); 2010 Jun; 70(3):213-4. PubMed ID: 20734583
[No Abstract] [Full Text] [Related]
5. Bad medicine. Monitoring programs target substandard drugs.
Grens K
Mod Healthc; 2013 May; 43(20):30-1. PubMed ID: 23947275
[No Abstract] [Full Text] [Related]
6. Pharmaceutical counterfeiting.
Deisingh AK
Analyst; 2005 Mar; 130(3):271-9. PubMed ID: 15724152
[TBL] [Abstract][Full Text] [Related]
7. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
Nsimba SE
East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
[TBL] [Abstract][Full Text] [Related]
8. Counterfeiting and piracy of pharmaceuticals.
Grackin A
IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
[No Abstract] [Full Text] [Related]
9. Drugs, drugs--who has the drugs?
Blair J
J Healthc Prot Manage; 2012; 28(1):28-32. PubMed ID: 22423518
[TBL] [Abstract][Full Text] [Related]
10. WHO tries to tackle problem of counterfeit medicines in Asia.
Pincock S
BMJ; 2003 Nov; 327(7424):1126. PubMed ID: 14615319
[No Abstract] [Full Text] [Related]
11. Indian generics manufacturer Ranbaxy agrees to pay $500m to settle US fraud and drug safety charges.
Kay M
BMJ; 2013 May; 346():f3536. PubMed ID: 23723460
[No Abstract] [Full Text] [Related]
12. New countermeasures considered as drug counterfeiting grows.
Schubert C
Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
[No Abstract] [Full Text] [Related]
13. Rationale drug therapy: reasons for failure and suggestions for its implementation.
Mathur GP; Kushwaha KP; Mathur S
Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879
[No Abstract] [Full Text] [Related]
14. Spurious and counterfeit drugs: a growing industry in the developing world.
Gautam CS; Utreja A; Singal GL
Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
[TBL] [Abstract][Full Text] [Related]
15. WHO to set up international task force on counterfeit drugs.
Zarocostas J
BMJ; 2006 Feb; 332(7539):444. PubMed ID: 16497756
[No Abstract] [Full Text] [Related]
16. The "spurious drugs" gene and its pervasiveness.
Srinivasan S
Indian J Med Ethics; 2010; 7(3):136-9. PubMed ID: 20806518
[No Abstract] [Full Text] [Related]
17. Russia cracks down on counterfeit drugs.
Parfitt T
Lancet; 2006 Oct; 368(9546):1481-2. PubMed ID: 17078121
[No Abstract] [Full Text] [Related]
18. [Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].
Tamir O; Friedman N; Furman-Assaf S; Marom E; Arieli M; Shemer J
Harefuah; 2010 Jul; 149(7):466-9, 479. PubMed ID: 21465763
[TBL] [Abstract][Full Text] [Related]
19. Counterfeit pharmaceuticals: current status and future projections.
Wertheimer AI; Chaney NM; Santella T
J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
[TBL] [Abstract][Full Text] [Related]
20. Health risks of counterfeit pharmaceuticals.
ten Ham M
Drug Saf; 2003; 26(14):991-7. PubMed ID: 14583061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
